MRSA Researchers Identify New Class of Drug Effective Against Superbug, Ohio State University Wexner Medical Center Study
Published: Oct 10, 2012
In two separate studies, researchers at The Ohio State University Wexner Medical Center have discovered a new class of treatment against methicillin-resistant Staphylococcus aureus (MRSA) as well as evidence of a growing need to quickly genotype individual strains of the organism most commonly referred to as the "superbug." "The public is most familiar with the dramatic progression of skin infections caused by MRSA, but MRSA is responsible for a range of difficult to treat illnesses," noted Dr. Kurt B. Stevenson, an infectious disease expert at Ohio State, and primary investigator of one of the studies following the transmission of MRSA infections in communities. "While we've seen a decrease in the number of MRSA cases, identifying new drug treatments and tracking methods will be critical to stopping these infections before they can start."